ATE356622T1 - Einen lipase-inhibitor und einen saccharosefettsäuremonoester enthaltende pharmazeutische zusammensetzung - Google Patents

Einen lipase-inhibitor und einen saccharosefettsäuremonoester enthaltende pharmazeutische zusammensetzung

Info

Publication number: ATE356622T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; fatty acid; composition containing; sucrose fatty; acid monoester
Prior art date: 2001-06-06

Application number

AT02727607T

Other languages

English (en)

Inventor

Karsten Maeder

Rainer Eugen Martin

Susanne Raab

Lukas Christoph Scheibler

Thomas Schindler

Marco Schroeder

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-06

Filing date

2002-05-29

Publication date

2007-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8177654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE356622(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-05-29 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2007-04-15 Application granted granted Critical

2007-04-15 Publication of ATE356622T1 publication Critical patent/ATE356622T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Obesity (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Nutrition Science (AREA)
Zoology (AREA)
Physiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT02727607T 2001-06-06 2002-05-29 Einen lipase-inhibitor und einen saccharosefettsäuremonoester enthaltende pharmazeutische zusammensetzung ATE356622T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01113793		2001-06-06

Publications (1)

Publication Number	Publication Date
ATE356622T1 true ATE356622T1 (de)	2007-04-15

Family

ID=8177654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02727607T ATE356622T1 (de)	2001-06-06	2002-05-29	Einen lipase-inhibitor und einen saccharosefettsäuremonoester enthaltende pharmazeutische zusammensetzung

Country Status (40)

Country	Link
US (4)	US20030027786A1 (de)
EP (1)	EP1399152B1 (de)
JP (2)	JP4261337B2 (de)
KR (1)	KR100753729B1 (de)
CN (1)	CN1514725B (de)
AR (1)	AR034355A1 (de)
AT (1)	ATE356622T1 (de)
AU (1)	AU2002257817B2 (de)
BG (1)	BG66346B1 (de)
BR (1)	BRPI0210266B1 (de)
CA (1)	CA2448030C (de)
CO (1)	CO5540293A2 (de)
CY (1)	CY1107641T1 (de)
CZ (1)	CZ299948B6 (de)
DE (1)	DE60218845T2 (de)
DK (1)	DK1399152T3 (de)
EC (1)	ECSP034871A (de)
ES (1)	ES2282415T3 (de)
GT (1)	GT200200106A (de)
HK (1)	HK1067312A1 (de)
HR (1)	HRP20030983B1 (de)
HU (1)	HU230405B1 (de)
IL (2)	IL158908A0 (de)
JO (1)	JO2455B1 (de)
MA (1)	MA27031A1 (de)
ME (1)	ME00579A (de)
MX (1)	MXPA03011191A (de)
MY (1)	MY161871A (de)
NO (1)	NO328006B1 (de)
NZ (1)	NZ529630A (de)
PA (1)	PA8546701A1 (de)
PE (1)	PE20030230A1 (de)
PL (1)	PL215266B1 (de)
PT (1)	PT1399152E (de)
RS (1)	RS50713B (de)
RU (1)	RU2271808C2 (de)
SI (1)	SI1399152T1 (de)
SK (1)	SK287602B6 (de)
WO (1)	WO2002098412A1 (de)
ZA (1)	ZA200309007B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030027786A1 (en) *	2001-06-06	2003-02-06	Karsten Maeder	Lipase inhibiting composition
US8372430B2 (en)	2002-12-17	2013-02-12	The Procter & Gamble Company	Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
FI20045076L (fi) *	2004-03-15	2005-09-16	Bioferme Oy	Funktionaalinen elintarvike
KR100910000B1 (ko) *	2005-05-13	2009-07-29	씨제이제일제당 (주)	리파아제 저해제 함유 약학 조성물
WO2006132440A1 (ja) *	2005-06-09	2006-12-14	Takeda Pharmaceutical Company Limited	固形製剤
US20070111914A1 (en) *	2005-11-16	2007-05-17	Conopco, Inc., D/B/A Unilever, A Corporation Of New York	Environmentally friendly laundry method and kit
KR101252635B1 (ko) *	2006-04-20	2013-04-10	(주)아모레퍼시픽	리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
EP1872777A1 (de) *	2006-06-27	2008-01-02	LEK Pharmaceuticals D.D.	Pharmazeutische Zusammensetzung enthaltend Tetrahydrolipstatin
GB0618725D0 (en) *	2006-09-23	2006-11-01	Jagotec Ag	Composition containing inhibitors of gastro-intestinal lipase
PL216542B1 (pl)	2008-03-20	2014-04-30	Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna	Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
US8309107B2 (en) *	2008-10-06	2012-11-13	Banner Pharmacaps, Inc.	Stable solutions of orlistat for pharmaceutical dosage forms
FR2994386B1 (fr) *	2012-08-07	2016-06-24	Thorel Jean-Noel	Inhibition de l'adhesion de micro-organismes pathogenes par un ester de saccharose et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
US10743813B2 (en)	2014-09-11	2020-08-18	Rattan Nath	Diabetes control using postprandial feedback
CN104546768B (zh) *	2014-12-30	2017-06-16	重庆植恩药业有限公司	含有脂肪酶抑制剂的咀嚼片组合物及其制备方法
EP3364956A4 (de)	2015-10-23	2019-05-01	ERX Pharmaceuticals, Inc.	Analoga von celastrol
CN113151373B (zh) *	2021-03-09	2023-07-04	武汉臻治生物科技有限公司	一种具有抗菌及抗肿瘤活性的蔗糖单酯的制备方法及其应用
KR102637596B1 (ko)	2022-03-18	2024-02-19	(주)보노보씨	기능성 목공교구

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1965133A1 (de)	1969-12-27	1971-07-22	Merck Patent Gmbh	Verfahren zur Herstellung pharmazeutischer Zubereitungen
US4148893A (en) *	1977-06-13	1979-04-10	The Procter & Gamble Company	Dermatological compositions
CA1247547A (en) *	1983-06-22	1988-12-28	Paul Hadvary	Leucine derivatives
CA1270837A (en)	1984-12-21	1990-06-26	Hoffmann-La Roche Limited	Oxetanones
CA1328881C (en)	1984-12-21	1994-04-26	Pierre Barbier	Process for the manufacture of oxetanones
NL8600050A (nl)	1986-01-13	1987-08-03	Sanico Nv	Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van.
EP0271963B1 (de) *	1986-12-19	1993-07-21	The Procter & Gamble Company	Nährzusammenstellung mit höherem Blutcholesterol herabsetzenden Eigenschaften
JP2748597B2 (ja)	1989-09-28	1998-05-06	三菱化学株式会社	食品劣化抑制剤
CA2035972C (en)	1990-02-23	2006-07-11	Martin Karpf	Process for the preparation of oxetanones
JP3112473B2 (ja)	1990-10-18	2000-11-27	オリンパス光学工業株式会社	屈折率分布型光学素子の製造方法
US5294451A (en) *	1991-03-29	1994-03-15	Curtice-Burns, Inc.	Fat substitute compositions having reduced laxative effects
US5274143A (en)	1991-07-23	1993-12-28	Hoffmann-La Roche Inc.	Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
FR2735658B1 (fr) *	1995-06-21	1997-09-12	Capsulis	Encapsulation de composes a usage alimentaire par des tensioactifs
CA2098167C (en) *	1992-06-24	2006-12-19	Dorothea Isler	Foodstuffs and feedstuffs containing a lipase inhibitor
US6004996A (en) *	1997-02-05	1999-12-21	Hoffman-La Roche Inc.	Tetrahydrolipstatin containing compositions
US6267952B1 (en)	1998-01-09	2001-07-31	Geltex Pharmaceuticals, Inc.	Lipase inhibiting polymers
JP3774118B2 (ja) *	1998-08-14	2006-05-10	エフ．ホフマン−ラロシュアーゲー	リパーゼ阻害剤を含む製薬学的組成物
BR9912979B1 (pt) *	1998-08-14	2010-09-21		composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
AU1031500A (en)	1998-11-03	2000-05-22	Dandy A/S	Sucrose fatty acid esters for use as increased release of active ingredients
GB9900416D0 (en)	1999-01-08	1999-02-24	Alizyme Therapeutics Ltd	Inhibitors
AR025609A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones lipidas solidas
AR025587A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones en dispersion que contienen inhibidores de lipasa
IL144045A0 (en)	1999-10-29	2002-04-21	Mullins John Jason Gentry	Oxetanone derivatives
US6348492B1 (en)	1999-10-29	2002-02-19	2Pro Chemical	Oxetanone derivatives
CN1236764C (zh) *	2000-06-27	2006-01-18	霍夫曼-拉罗奇有限公司	制备组合物的方法
ATE293477T1 (de) *	2000-07-28	2005-05-15	Hoffmann La Roche	Neue verwendung von lipase-inhibitoren
US20030027786A1 (en) *	2001-06-06	2003-02-06	Karsten Maeder	Lipase inhibiting composition
US6534097B1 (en) *	2002-07-11	2003-03-18	Betty Baggott	Pest repellent

2002
- 2002-05-23 US US10/154,494 patent/US20030027786A1/en not_active Abandoned
- 2002-05-29 SI SI200230524T patent/SI1399152T1/sl unknown
- 2002-05-29 NZ NZ529630A patent/NZ529630A/en not_active IP Right Cessation
- 2002-05-29 IL IL15890802A patent/IL158908A0/xx active IP Right Grant
- 2002-05-29 WO PCT/EP2002/005889 patent/WO2002098412A1/en active IP Right Grant
- 2002-05-29 RU RU2003136728/15A patent/RU2271808C2/ru active
- 2002-05-29 CZ CZ20033525A patent/CZ299948B6/cs not_active IP Right Cessation
- 2002-05-29 DK DK02727607T patent/DK1399152T3/da active
- 2002-05-29 PL PL366890A patent/PL215266B1/pl unknown
- 2002-05-29 KR KR1020037015985A patent/KR100753729B1/ko active IP Right Grant
- 2002-05-29 JP JP2003501451A patent/JP4261337B2/ja not_active Expired - Fee Related
- 2002-05-29 HU HU0401208A patent/HU230405B1/hu unknown
- 2002-05-29 RS YUP-960/03A patent/RS50713B/sr unknown
- 2002-05-29 ES ES02727607T patent/ES2282415T3/es not_active Expired - Lifetime
- 2002-05-29 CN CN028114957A patent/CN1514725B/zh not_active Expired - Lifetime
- 2002-05-29 ME MEP-904/08A patent/ME00579A/xx unknown
- 2002-05-29 CA CA002448030A patent/CA2448030C/en not_active Expired - Lifetime
- 2002-05-29 DE DE60218845T patent/DE60218845T2/de not_active Expired - Lifetime
- 2002-05-29 EP EP02727607A patent/EP1399152B1/de not_active Expired - Lifetime
- 2002-05-29 PT PT02727607T patent/PT1399152E/pt unknown
- 2002-05-29 AU AU2002257817A patent/AU2002257817B2/en not_active Expired
- 2002-05-29 MX MXPA03011191A patent/MXPA03011191A/es active IP Right Grant
- 2002-05-29 SK SK1609-2003A patent/SK287602B6/sk not_active IP Right Cessation
- 2002-05-29 BR BRPI0210266A patent/BRPI0210266B1/pt not_active IP Right Cessation
- 2002-05-29 AT AT02727607T patent/ATE356622T1/de active
- 2002-06-02 JO JO200254A patent/JO2455B1/en active
- 2002-06-04 PA PA20028546701A patent/PA8546701A1/es unknown
- 2002-06-04 AR ARP020102074A patent/AR034355A1/es not_active Application Discontinuation
- 2002-06-04 MY MYPI20022058A patent/MY161871A/en unknown
- 2002-06-05 GT GT200200106A patent/GT200200106A/es unknown
- 2002-06-05 PE PE2002000472A patent/PE20030230A1/es active IP Right Grant
2003
- 2003-11-17 IL IL158908A patent/IL158908A/en unknown
- 2003-11-19 ZA ZA2003/09007A patent/ZA200309007B/en unknown
- 2003-11-26 HR HR20030983A patent/HRP20030983B1/xx not_active IP Right Cessation
- 2003-11-28 NO NO20035318A patent/NO328006B1/no not_active IP Right Cessation
- 2003-12-01 EC EC2003004871A patent/ECSP034871A/es unknown
- 2003-12-02 CO CO03106075A patent/CO5540293A2/es active IP Right Grant
- 2003-12-03 MA MA27421A patent/MA27031A1/fr unknown
- 2003-12-05 BG BG108421A patent/BG66346B1/bg unknown
2004
- 2004-12-23 US US11/019,865 patent/US8039508B2/en not_active Expired - Lifetime
- 2004-12-30 HK HK04110347.5A patent/HK1067312A1/xx not_active IP Right Cessation
2007
- 2007-05-29 CY CY20071100716T patent/CY1107641T1/el unknown
2008
- 2008-11-12 JP JP2008289389A patent/JP2009108076A/ja active Pending
2011
- 2011-08-19 US US13/213,379 patent/US8343543B2/en not_active Expired - Fee Related
2012
- 2012-11-26 US US13/684,698 patent/US20130079391A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CZ20033525A3 (cs)	2004-04-14
CN1514725B (zh)	2010-04-21
IL158908A (en)	2008-08-07
DK1399152T3 (da)	2007-06-18
ME00579B (me)	2011-12-20
SK287602B6 (sk)	2011-03-04
RS50713B (sr)	2010-06-30
US20130079391A1 (en)	2013-03-28
CY1107641T1 (el)	2013-04-18
US20110301231A1 (en)	2011-12-08
PE20030230A1 (es)	2003-03-17
AU2002257817B2 (en)	2005-08-18
ZA200309007B (en)	2005-04-26
PL215266B1 (pl)	2013-11-29
DE60218845T2 (de)	2008-01-03
IL158908A0 (en)	2004-05-12
RU2003136728A (ru)	2005-05-20
EP1399152B1 (de)	2007-03-14
CA2448030A1 (en)	2002-12-12
NO328006B1 (no)	2009-11-09
AR034355A1 (es)	2004-02-18
MY161871A (en)	2017-05-15
PA8546701A1 (es)	2003-01-24
SK16092003A3 (sk)	2004-05-04
JO2455B1 (en)	2008-10-09
HU230405B1 (hu)	2016-04-28
HUP0401208A2 (hu)	2004-11-29
EP1399152A1 (de)	2004-03-24
MXPA03011191A (es)	2004-02-26
WO2002098412A1 (en)	2002-12-12
BRPI0210266B1 (pt)	2016-01-26
MA27031A1 (fr)	2004-12-20
ECSP034871A (es)	2004-01-28
HK1067312A1 (en)	2005-04-08
CN1514725A (zh)	2004-07-21
BR0210266A (pt)	2004-07-20
HRP20030983A2 (en)	2005-08-31
RU2271808C2 (ru)	2006-03-20
BG66346B1 (bg)	2013-08-30
RS96003A (en)	2006-10-27
US20030027786A1 (en)	2003-02-06
HUP0401208A3 (en)	2008-04-28
NZ529630A (en)	2006-05-26
HRP20030983B1 (en)	2011-10-31
US8039508B2 (en)	2011-10-18
PL366890A1 (en)	2005-02-07
ME00579A (en)	2011-12-20
US20050101562A1 (en)	2005-05-12
GT200200106A (es)	2003-02-11
SI1399152T1 (sl)	2007-08-31
CO5540293A2 (es)	2005-07-29
JP2009108076A (ja)	2009-05-21
JP2004532271A (ja)	2004-10-21
BG108421A (en)	2005-02-28
CA2448030C (en)	2009-11-24
DE60218845D1 (de)	2007-04-26
JP4261337B2 (ja)	2009-04-30
NO20035318D0 (no)	2003-11-28
KR20040010689A (ko)	2004-01-31
KR100753729B1 (ko)	2007-08-30
US8343543B2 (en)	2013-01-01
ES2282415T3 (es)	2007-10-16
PT1399152E (pt)	2007-06-05
CZ299948B6 (cs)	2009-01-07

Publication	Publication Date	Title
ATE356622T1 (de)	2007-04-15	Einen lipase-inhibitor und einen saccharosefettsäuremonoester enthaltende pharmazeutische zusammensetzung
ATE293970T1 (de)	2005-05-15	Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ATE503462T1 (de)	2011-04-15	Pharmazeutische zusammensetzungen mit cholesteryl ester transfer protein inhibitoren
NO20020090D0 (no)	2002-01-08	Farmasöytiske og n¶ringsformuleringer inneholdende essensielle fettsyrer og homocystein-senkende midler
ATE263558T1 (de)	2004-04-15	Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
DK1399153T3 (da)	2008-01-07	Farmaceutisk præparat indeholdende orlistat og en fedtsyre eller et salt deraf
IL216931A (en)	2015-11-30	A pharmacy composition containing Mumtson's Azalastine and Aster
GB2409644B (en)	2005-12-21	Formulation comprising eicosapentaenoic acid or an ester thereof and a triterpene or an ester thereof
IS6254A (is)	2002-01-29	Lyfjasamsetningar sem innihalda HMG afoxunarensímlata
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
ATE355271T1 (de)	2006-03-15	Pharmazeutische zusammensetzung
DE60307677D1 (de)	2006-09-28	Dispergierbare pharmazeutische zusammensetzungen
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
ATE320244T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen mit amlodipinmaleat
ATE298571T1 (de)	2005-07-15	Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
DE60213592D1 (de)	2006-09-14	Flüssige pharmazeutische zusammensetzung
ITMI20020731A0 (it)	2002-04-08	Composizioni farmaceutiche per acido acetilsalicilico e oli omega-3
NO20020086L (no)	2002-03-05	Smaksmaskerte farmasöytiske flytende formuleringer
ATE429224T1 (de)	2009-05-15	Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
DK1200118T3 (da)	2008-04-21	En farmaceutisk sammensætning omfattende megalatran og dens prodrug
DE60330764D1 (de)	2010-02-11	Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
ATE366128T1 (de)	2007-07-15	Pharmazeutische zusammensetzung
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE439362T1 (de)	2009-08-15	Ester in position 20 von camptothecinen
EE200300468A (et)	2004-02-16	Pravastatiini stabiilne farmatseutiline kompositsioon

Legal Events

Date	Code	Title	Description
2007-09-15	UEP	Publication of translation of european patent specification	Ref document number: 1399152 Country of ref document: EP

Date

Code

Title

Description

2007-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1399152

Country of ref document: EP